Avivomed Inc.

Biotech Roseville, MN

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Roseville, MN
Street
2896 Centre Pointe Drive
Zip
55113

Offering

Total offering
$12M
Amount sold
$5M
First sale
Apr 16, 2026
Min investment
$0
Securities
Debt
Federal exemption
Rule 506(b)
Investors so far
7

How this filing compares

Ranked #8 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 4.0× the median.

Other Minnesota filings this week: Nascent Surgical Holdings, LLC, Rise Opportunities 15 LLC, STILLY SPIRITS LLC, AdvisorNet Financial, Inc, Outlier Fund, L.P.

Leadership

Paul Mazanec — Executive Officer (also: Director)

Mudit K. Jain — Director

Ketan Patel — Director

Also named on: Rainmaker Capital LLC

Theresa C. Pappas — Director

Casper de Clercq — Director

Also named on: Route 92 Medical, Inc.

Douglas Reed — Director

Also named on: Hatteras CREATE SF SPV, LLC

Filing details

Avivomed Inc. filed a Form D with the SEC on April 21, 2026.

Other newest Biotech companies

Other newest companies in Minnesota